We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$14.6B
AUM Growth
-$1.02B
Cap. Flow
-$902M
Cap. Flow %
-6.19%
Top 10 Hldgs %
33.67%
Holding
1,168
New
194
Increased
342
Reduced
403
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$56M
2
CSCO icon
Cisco
CSCO
+$49.4M
3
META icon
Meta Platforms (Facebook)
META
+$45.4M
4
CVE icon
Cenovus Energy
CVE
+$40.5M
5
BNS icon
Scotiabank
BNS
+$39.8M

Sector Composition

Rank Sector Weight
1 Financials 27.48%
2 Energy 13.55%
3 Industrials 13.52%
4 Technology 10.79%
5 Materials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
476
Regeneron Pharmaceuticals
REGN
$83B
$1.48M 0.01%
5,325
-12,225
-70% -$3.62M
VEEV icon
477
Veeva Systems
VEEV
$41B
$1.47M 0.01%
+9,650
New +$1.55M
TNAV
478
DELISTED
Telenav Inc.
TNAV
$1.46M 0.01%
305,000
+249,693
+451% +$2.1M
HDS
479
DELISTED
HD Supply Holdings, Inc.
HDS
$1.46M 0.01%
+37,175
New +$1.46M
SMPL icon
480
Simply Good Foods
SMPL
$989M
$1.46M 0.01%
+50,200
New +$1.4M
ODP
481
DELISTED
ODP
ODP
$1.45M 0.01%
82,852
+6,173
+8% +$106K
MKTX icon
482
MarketAxess Holdings
MKTX
$5.72B
$1.44M 0.01%
+4,400
New +$1.57M
INCY icon
483
Incyte
INCY
$24.4B
$1.44M 0.01%
19,375
+12,975
+203% +$1.05M
NXGN
484
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.4M 0.01%
89,513
-28,300
-24% -$471K
BIDU icon
485
Baidu
BIDU
$35.5B
$1.4M 0.01%
13,629
+2,825
+26% +$304K
DHX icon
486
DHI Group
DHX
$174M
$1.4M 0.01%
362,652
+9,925
+3% +$36.9K
TCOM icon
487
Trip.com Group
TCOM
$28.3B
$1.38M 0.01%
47,175
+16,450
+54% +$578K
IBN icon
488
ICICI Bank
IBN
$106B
$1.38M 0.01%
113,336
+42,225
+59% +$495K
DAL icon
489
Delta Air Lines
DAL
$60B
$1.38M 0.01%
+23,900
New +$1.42M
DNR
490
DELISTED
Denbury Resources, Inc.
DNR
$1.36M 0.01%
1,141,115
-465,512
-29% -$537K
CSTM icon
491
Constellium
CSTM
$3.95B
$1.35M 0.01%
+106,475
New +$1.25M
GCO icon
492
Genesco
GCO
$394M
$1.34M 0.01%
33,575
+23,275
+226% +$898K
HDB icon
493
HDFC Bank
HDB
$119B
$1.34M 0.01%
47,000
+8,600
+22% +$245K
MELI icon
494
Mercado Libre
MELI
$92.7B
$1.32M 0.01%
2,400
-200
-8% -$121K
OVV icon
495
Ovintiv
OVV
$17.2B
$1.32M 0.01%
57,713
-772,192
-93% -$17.7M
ATVI
496
DELISTED
Activision Blizzard
ATVI
$1.3M 0.01%
24,632
-16,200
-40% -$808K
ELV icon
497
Elevance Health
ELV
$86.4B
$1.3M 0.01%
+5,425
New +$1.49M
EPRT icon
498
Essential Properties Realty Trust
EPRT
$6.71B
$1.3M 0.01%
+56,781
New +$1.22M
FTNT icon
499
Fortinet
FTNT
$121B
$1.3M 0.01%
84,625
-60,750
-42% -$986K
WLFC icon
500
Willis Lease Finance
WLFC
$1.15B
$1.3M 0.01%
70,266
-4,884
-6% -$98.5K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2019 Portfolio in Review

As of Q3 2019, Connor, Clark & Lunn Investment Management (CC&L) held 1,168 positions worth $14.6B, down 6.5% from $15.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $902M in Q3 2019, closing 225 positions and reducing 403 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $37.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Fidelity National Information Services worth $29.9M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2019 buy was Fidelity National Information Services: 225,271 shares worth $29.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Pfizer in Q3 2019, an estimated $56M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2019 reduction was Toronto Dominion Bank, cutting an estimated $105M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Bristol-Myers Squibb in Q3 2019, selling an estimated $37.2M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 34% of its $14.6B portfolio in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 194 new positions and closed 225 in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 6.5% quarter-over-quarter to $14.6B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2019, filed 13 Nov 2019.